IP Library Granted Patent US 9,533,933
Granted Patent B2
US 9,533,933 · App. 14/815,014 · Granted Jan 3, 2017

Process for preparing cyclododecanone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,533,933
App. No.
14/815,014
Granted
Jan 3, 2017
Kind
B2
Abstract

Cyclododecanone (CDON) is prepared by epoxidizing cyclododecene (CDEN) to epoxycyclododecane (CDAN epoxide), and rearranging the CDAN epoxide to CDON to obtain a mixture comprising said CDON and CDEN, wherein CDEN is separated from the CDON-containing mixture and sent to the epoxidation to CDAN epoxide in step a.

Claims (22)

1. A process for preparing cyclododecanone (CDON) by a reaction route I, comprising

a. epoxidizing cyclododecene (CDEN) to epoxycyclododecane (CDAN epoxide), and

b. rearranging the CDAN epoxide to CDON to obtain a mixture comprising said CDON and CDEN,

wherein:

CDEN is separated from the CDON-containing mixture and sent to the epoxidation to CDAN epoxide in step a;

the CDAN epoxide from step a comprises cyclododecane (CDAN) which is at least partly removed prior to the rearrangement in step b; and

the CDAN removed prior to the rearrangement in step b is sent to a reaction route II for preparation of CDON, comprising:

c. hydrogenation of cyclododecatriene (CDT) to CDAN,

d. oxidation of CDAN to give a mixture comprising cyclododecanol (CDOL) and CDON and

e. dehydrogenation of CDOL to CDON.

2. The process according to claim 1 , wherein CDEN for the epoxidation in step a is obtained from cyclododecatriene (CDT).

3. The process according to claim 1 , wherein the rearrangement in step b is effected in the presence of a noble metal catalyst.

4. The process according to claim 3 , wherein the catalyst for the rearrangement (step b) comprises titanium dioxide, zirconium dioxide or both.

5. The process according to claim 1 , wherein the CDAN epoxide from step a comprises CDEN which is at least partly removed prior to the rearrangement in step b.

6. The process according to claim 1 , wherein the CDON-containing mixture comprises cyclododecanol (CDOL) which is dehydrogenated to CDON.

7. The process according to claim 6 , wherein the CDOL is separated from the CDON-containing mixture prior to the dehydrogenation and is sent to the reaction route II for preparation of CDON.

8. The process according to claim 1 , wherein at least one removal of any compound is conducted by distillation.

9. The process according to claim 1 , wherein all removals of any compound are conducted by distillation.

10. The process according to claim 1 , wherein CDT is obtained from 1,3-butadiene.

11. A process for synthesizing laurolactam from CDON, wherein the CDON is prepared according to claim 1 .

12. The process according to claim 11 , wherein the CDON is converted to cyclododecanone oxime (CDON oxime).

13. A process for preparing nylon-12 from CDON, wherein the CDON is prepared according to claim 1 .

Assignments (2)
CHANGE OF NAME Recorded Jan 31, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051765/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2015
From: MICOINE, KEVIN; MEIER, RALF; HERWIG, JUERGEN; ROOS, MARTIN; HAEGER, HARALD; CAMERETTI, LUCA; DOERING, JENS
To: EVONIK DEGUSSA GMBH
Reel/Frame 036850/0149 →